Dopaminergic control of sleep-wake states

Journal of Neuroscience

Volumn 26, Issue 41, 2006, Pages 10577-10589

  Dzirasa, Kafui ^a   Ribeiro, Sidarta ^a   Costa, Rui ^a,b   Santos, Lucas M ^a   Lin, Shih Chieh ^a   Grosmark, Andres ^a   Sotnikova, Tatyana D ^a   Gainetdinov, Raul R ^a   Caron, Marc G ^a   Nicolelis, Miguel A L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Dopamine; Parkinson's; Psychosis; REM; Schizophrenia; Sleep

Indexed keywords

HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ELECTROPHYSIOLOGY; HIPPOCAMPUS; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; WAKEFULNESS;

ANIMALS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EXPLORATORY BEHAVIOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; PARKINSON DISEASE; SLEEP STAGES; WAKEFULNESS;

EID: 33749866591     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1767-06.2006     Document Type: Article

References (65)

1. Abbott A (2005) Neuroscience: while you were sleeping. Nature 437:1220-1222.
2. Adler CH (2005) Nonmotor complications in Parkinson's disease. Mov Disord 20:S23-S29.
3. Aserinsky E, Kleitman N (1953) Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 118:273-274.
4. Aston-Jones G, Bloom FE (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876-886.
5. Bjorklund A, Lindvall O (1984) Dopamine-containing systems in the CNS. In: Handbook of chemical neuroanatomy (Hokfelt T, ed), pp 52-122. Amsterdam: Elsevier.
6. Boissard R, Gervasoni D, Schmidt MH, Barbagli B, Fort P, Luppi PH (2002) The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur J Neurosci 16:1959-1973.
7. 2 dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats. J Neurosci 20:1849-1857.
8. Cantero JL, Atienza M, Stickgold R, Kahana MJ, Madsen JR, Kocsis B (2003) Sleep-dependent theta oscillations in the human hippocampus and neocortex. J Neurosci 23:10897-10903.
9. Carlsson A (1987) Perspectives on the discovery of central monoaminergic neurotransmission. Annu Rev Neurosci 10:19-40.
10. Costa RM, Lin SC, Sotnikova TD, Gainetdinov RR, Cyr M, Caron MG, Nicolelis MAL (2006) Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron, in press.
11. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
12. Crochet S, Sakai K (1999) Effects of microdialysis application of monoamines on the EEG and behavioural states in the cat mesopontine tegmentum. Eur J Neurosci 10:3738-3752.
13. Dement WC, Kleitman N (1957a) The relation of eye movements during sleep to dream activity: an objective method for the study of dreaming. J Exp Psychol 53:339-346.
14. Dement W, Kleitman N (1957b) Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr Clin Neurophysiol Suppl 9:673-690.
15. Epstein J, Stern E, Silbersweig D (1999) Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies. Ann NY Acad Sci 877:562-574.
16. Espana RA, Scammell TE (2004) Sleep neurobiology for the clinician. Sleep 27:811-820.
17. Fahn S (2003) Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci 991:1-14.
18. Foulkes WD (1962) Dream reports from different stages of sleep. J Abnorm Soc Psychol 65:14-25.
19. Freud S (1900) The interpretation of dreams, 1952 edition. London: Encyclopaedia Britannica.
20. Gagnon JF, Bedard MA, Fantini ML, Petit D, Panisset M, Rompre S, Carrier J, Montplaisir J (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 59:585-589.
21. Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261-284.
22. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283:397-401.
23. Gainetdinov RR, Mohn AR, Bohn LM, Caron MG (2001) Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proc Natl Acad Sci USA 98:11047-11054.
24. Gervasoni D, Lin SC, Ribeiro S, Soares ES, Pantoja P, Nicolelis M (2004) Global forebrain dynamics predict rat behavioral states and their transitions. J Neurosci 24:11137-11147.
25. Gottesmann C (2005) Dreaming and schizophrenia: a common neurobiological background. Sleep Biol Rhythms 3:64-74.
26. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR (2006) Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 11:125-133,115.
27. Guix T, Hurd YL, Ungerstedt U (1992) Amphetamine enhances extracellular concentrations of dopamine and acetylcholine in dorsolateral striatum and nucleus accumbens of freely moving rats. Neurosci Lett 138:137-140.
28. Hartmann E (1976) Schizophrenia: a theory. Psychopharmacol (Berl) 49:1-15.
29. Heynick F (1993) Language and its dream disturbance. Toronto: Wiley.
30. Hobson JA, Pace-Schott EF (2002) The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nat Rev Neurosci 3:679-693.
31. Hobson JA, Datta S, Calvo JM, Quattrochi J (1993) Acetylcholine as a brain state modulator - triggering and long-term regulation of REM sleep. In: Cholinergic function and dysfunction (Cuello AC, ed), pp 389-404. Amsterdam: Elsevier.
32. Hobson JA, Stickgold R, Pace-Schott EF (1998) The neuropsychology of REM sleep dreaming. NeuroReport 9:R1-R14.
33. Jenkins RB, Groh RH (1970) Mental symptoms in Parkinsonian patients treated with L-dopa. Lancet 2:177-179.
34. John J, Wu MF, Boehmer LN, Siegel JM (2004) Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42:619-634.
35. Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18:1979-1986.
36. Jouvet M, Michel F, Courjon J (1959) On a stage of rapid cerebral electrical activity in the course of physiological sleep. C R Seances Soc Biol Fil 153:1024-1028.
37. Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 7:837-844.
38. Kaur S, Panchal M, Faisal M, Madan V, Nangia P, et al. (2004) Long term blocking of GABA-A receptor in locus coeruleus by bilateral microinfusion of picrotoxin reduced rapid eye movement sleep and increased brain Na-K ATPase activity in freely moving normally behaving rats. Behav Brain Res 151:185-190.
39. Kichigina VF (2004) Dopaminergic regulation of theta activity of septohippocampal neuron in the awake rabbit. Zh Vyssh Nerv Deiat Im I P Pavlova 54:210-215.
40. Lena I, Parrot S, Deschaux O, Muffat-Joly S, Sauvinet V, Renaud B, Suaud-Chagny M, Gottesmann C (2005) Variations in extracellular levels of dopamine, noradrenaline, glutamate, and aspartate across the sleep-wake cycle in the medial prefrontal cortex and nucleus accumbens of freely moving rats. J Neurosci Res 81:891-899.
41. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, de Jong PJ, Nishino S, Mignot E (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98:365-376.
42. Maggini C, Guazzelli M, Pieri M, Lattanzi L, Ciapparelli A, Massimetti G, Rossi G (1986) REM latency in psychiatric disorders: polygraphic study on major depression, bipolar disorder-manic, and schizophrenic disorder. New Trends Exp Clin Psychiatry 2:93-101.
43. Maloney KJ, Mainville L, Jones BE (2002) c-Fos expression in dopaminergic and GABAergic neurons of the ventral mesencephalic tegmentum after paradoxical sleep deprivation and recovery. Eur J Neurosci 15:774-778.
44. Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49:724-736.
45. Miller JD, Farber J, Gatz P, Roffwarg H, German DC (1983) Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 273:133-141.
46. Miura Y, Ito T, Kadokawa T (1987) Effects of intraseptally injected dopamine and noradrenaline on hippocampal synchronized theta wave activity in rats. Jpn J Pharmacol 44:471-479.
47. Nilsson OG, Leanza G, Bjorklund A (1992) Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis. Brain Res 584:132-140.
48. O'Brien LM, Ivanenko A, Crabtree VM, Holbrook CR, Bruner JL, Klaus CJ, Gozal D (2003) ) Sleep disturbances in children with attention deficit hyperactivity disorder. Pediatr Res 54:237-243.
49. Ouyang M, Hellman K, Abel T, Thomas SA (2004) Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 92:2071-2082.
50. Park SP, Lopez-Rodriguez F, Wilson CL, Maidment N, Matsumoto Y, Engel JJ (1999) In vivo microdialysis measures of extracellular serotonin in the rat hippocampus during sleep-wakefulness. Brain Res 833:291-296.
51. Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257-1263.
52. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
53. Seeman P, Ko F, Tallerico T (2005) Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics. Mol Psychiatry 10:877-883.
54. Sharf B, Moskovitz C, Lupton MD, Klawans HL (1978) Dream phenomena induced by chronic levodopa therapy. J Neural Transm 43:143-151.
55. Snyder SH (1972) Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry 27:169-179.
56. Solms M (2000) Dreaming and REM sleep are controlled by different brain mechanisms. Behav Brain Sci 23:843-850.
57. Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 3:e271.
58. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behav Pharmacol 11:279-290.
59. Steriade M, McCormick DA, Sejnowski TJ (1993) Thalamocortical oscillations in the sleeping and aroused brain. Science 262:679-685.
60. Timo-Iaria C, Negrao N, Schmidek WR, Hoshino K, Lobato de Menezes CE, Leme da Rocha T (1970) Phases and states of sleep in the rat. Physiol Behav 5:1057-1062.
61. Trulson ME, Jacobs BL (1979) Raphe unit activity in freely moving cats: correlation with level of behavioral arousal. Brain Res 163:135-150.
62. Vanderwolf CH (1969) Hippocampal electrical activity and voluntary movement in the rat. Electroencephalogr Clin Neurophysiol 26:407-418.
63. Vanderwolf CH, Baker GB (1986) Evidence that serotonin mediates noncholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior. Brain Res 374:342-356.
64. Winson J (1974) Patterns of hippocampal theta rhythm in the freely moving rat. Electroencephalogr Clin Neurophysiol 36:291-301.
65. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM (2001) Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21:1787-1794.